Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter August 19, 2014

Influence of vitamin K antagonist treatment on activated partial thromboplastin time

Sylvie M.N. Mulliez, Julie Van den Bogaert and Katrien M.J. Devreese

Corresponding author: Katrien M.J. Devreese, Coagulation Laboratory, Laboratory for Clinical Biology Ghent University Hospital, De Pintelaan, 185 (2P8), 9000 Gent, Belgium, Phone: +32 9 3326567, Fax: +32 9 3324985, E-mail:

References

1. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed.). Chest 2008;133(Suppl): S187–98.10.1378/chest.08-0670Search in Google Scholar PubMed

2. Legnani C, Promenzio M, Guazzaloca G, Coccheri S, Palareti G. Assessment of activated partial thromboplastin time and factor IX in subjects attending an anticoagulation clinic. Blood Coagul Fibrin 2000;11:537–42.10.1097/00001721-200009000-00005Search in Google Scholar PubMed

3. Lawrie AS, Kitchen S, Efthymiou M, Mackie IJ, Machin SJ. Determination of APTT factor sensitivity – the misguiding guideline. Int J Lab Hematol 2013;35:652–7.10.1111/ijlh.12109Search in Google Scholar PubMed PubMed Central

4. Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009;7:1737–40.10.1111/j.1538-7836.2009.03555.xSearch in Google Scholar PubMed

5. D’Angelo A, Della Valle P, Crippa L, Fattorini A, Pattarini E, Vigano D’Angelo S. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment. Haematologica 2002;87:1074–80.Search in Google Scholar

6. Schouwers SM, Delanghe JR, Devreese KM. Lupus anticoagulant (LAC) testing in patients with inflammatory status: does C-reactive protein interfere with LAC test results? Thromb Res 2010;125:102–4.10.1016/j.thromres.2009.09.001Search in Google Scholar PubMed

7. van Rossum AP, Vlasveld LT, van den Hoven LJ, de Wit CW, Castel A. False prolongation of the activated partial thromboplastin time (aPTT) in inflammatory patients: interference of C-reactive protein. Br J Haematol 2012;157:394–5.10.1111/j.1365-2141.2011.08990.xSearch in Google Scholar PubMed


Supplemental Material

The online version of this article (DOI: 10.1515/cclm-2014-0688) offers supplementary material, available to authorized users.


Received: 2014-7-4
Accepted: 2014-7-21
Published Online: 2014-8-19
Published in Print: 2015-2-1

©2015 by De Gruyter

Scroll Up Arrow